Form D · Biotechnology
Ridge Diagnostics, Inc.
La Jolla, CA · CIK 0001493443
Offering snapshot reported Apr 18, 2013 · SEC filing
- Reported sold
- $250K Offering amount: $2.5M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Apr 5, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 18, 2013 | Initial | $250,000 | No comparison | 8 | SEC filing |
| Mar 19, 2012 | Initial | $6,605,440 | No comparison | 32 | SEC filing |
| Jun 11, 2010 | Initial | $577,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-195230
Source: Form D, filed Apr 18, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Bilello | Director, Executive |
| John Bilello, Ph.D. | Executive |
| Charles J. Cashion | Director |
| Gregory M. Decker | Executive |
| David F. Hale | Director |
| Karen A. Klause | Director |
| Ancelmo Lopes | Director |
| Bo Pi, Ph.D. | Executive |
| Perry Renshaw, M.D., Ph.D. | Executive |
| Stan Sewitch | Director |
| David Vandertie | Executive |
| Lonna J. Williams | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4225 Executive Square Suite 600
La Jolla, CA, 92037
La Jolla, CA, 92037